222 related articles for article (PubMed ID: 8093870)
1. Bleeding duodenal ulcer. Role of gastric acid hypersecretion.
Collen MJ; Kalloo AN; Sheridan MJ
Dig Dis Sci; 1993 Feb; 38(2):269-75. PubMed ID: 8093870
[TBL] [Abstract][Full Text] [Related]
2. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).
Collen MJ; Stanczak VJ; Ciarleglio CA
Dig Dis Sci; 1989 Feb; 34(2):233-7. PubMed ID: 2914544
[TBL] [Abstract][Full Text] [Related]
3. Gastric ulcers differ from duodenal ulcers. Evaluation of basal acid output.
Collen MJ; Sheridan MJ
Dig Dis Sci; 1993 Dec; 38(12):2281-6. PubMed ID: 8261834
[TBL] [Abstract][Full Text] [Related]
4. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.
Collen MJ; Johnson DA
Dig Dis Sci; 1992 Apr; 37(4):570-6. PubMed ID: 1551347
[TBL] [Abstract][Full Text] [Related]
5. Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation.
Collen MJ; Sheridan MJ
Dig Dis Sci; 1991 Oct; 36(10):1371-6. PubMed ID: 1914757
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of patients with multiple or giant peptic ulcers].
Csendes A; Becker P; Valenzuela J; Braghetto I; Csendes P
Rev Med Chil; 1991 Jan; 119(1):38-44. PubMed ID: 1824142
[TBL] [Abstract][Full Text] [Related]
7. Gastric acid secretion, parietal cell sensitivity, and endoscopic characteristics of duodenal ulcer patients with and without stigmata of recent bleeding.
Hui WM; Lam SK
Gastrointest Endosc; 1992; 38(3):361-4. PubMed ID: 1607090
[TBL] [Abstract][Full Text] [Related]
8. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.
Collen MJ; Johnson DA; Sheridan MJ
Dig Dis Sci; 1994 Feb; 39(2):410-7. PubMed ID: 8313826
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders.
Lewis JH
Aliment Pharmacol Ther; 1991; 5 Suppl 1():15-24. PubMed ID: 1888834
[TBL] [Abstract][Full Text] [Related]
10. Giant duodenal ulcer. Evaluation of basal acid output, nonsteroidal antiinflammatory drug use, and ulcer complications.
Collen MJ; Santoro MJ; Chen YK
Dig Dis Sci; 1994 May; 39(5):1113-6. PubMed ID: 8174425
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage].
Artal A; Lanas A; Barrao ME; Moliner FJ; Blas JM; López J
Rev Esp Enferm Dig; 1996 Mar; 88(3):191-6. PubMed ID: 8645512
[TBL] [Abstract][Full Text] [Related]
12. Gastric acid hypersecretion in refractory gastroesophageal reflux disease.
Collen MJ; Lewis JH; Benjamin SB
Gastroenterology; 1990 Mar; 98(3):654-61. PubMed ID: 2298369
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori in duodenal ulcer patients with idiopathic gastric acid hypersecretion.
Collen MJ; Strong RM
Dig Dis Sci; 1993 Jan; 38(1):132-6. PubMed ID: 8420745
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing.
Bianco A; Cagossi M; Piraccini R; Greco AV
Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062
[TBL] [Abstract][Full Text] [Related]
15. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine.
Reynolds JR; Walt RP; Clark AG; Hardcastle JD; Langman MJ
Aliment Pharmacol Ther; 1987 Feb; 1(1):23-30. PubMed ID: 2979209
[TBL] [Abstract][Full Text] [Related]
16. Gastric acid secretion and gastric emptying of liquids in 99 male duodenal ulcer patients.
Corinaldesi R; Stanghellini V; Paparo GF; Paternicò A; Giulia Rusticali A; Barbara L
Dig Dis Sci; 1989 Feb; 34(2):251-6. PubMed ID: 2914547
[TBL] [Abstract][Full Text] [Related]
17. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
Messmann H; Schaller P; Andus T; Lock G; Vogt W; Gross V; Zirngibl H; Wiedmann KH; Lingenfelser T; Bauch K; Leser HG; Schölmerich J; Holstege A
Endoscopy; 1998 Sep; 30(7):583-9. PubMed ID: 9826134
[TBL] [Abstract][Full Text] [Related]
18. The effects of fasting on 24-h gastric secretion of patients with duodenal ulcers resistant to ranitidine.
Johnston DA; Wormsley KG
Aliment Pharmacol Ther; 1989 Oct; 3(5):471-9. PubMed ID: 2518860
[TBL] [Abstract][Full Text] [Related]
19. Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate.
Marks IN; Johnston DA; Young GO
Am J Med; 1991 Aug; 91(2A):95S-101S. PubMed ID: 1882911
[TBL] [Abstract][Full Text] [Related]
20. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
